Do GLP users seek pleasure in scents?

Perfumers test their appetite for food-inspired fragrances.

One Essential Read One Essential Read Recommended by Kate Turton, Newsletter Editor Perfumers test weight-loss drug users' appetite for food-inspired scents   Staff demonstrate the testing process in the sensory area at the fragrance maker Coty in Versoix near Geneva, Switzerland. REUTERS/Denis Balibouse Today's One Essential Read is the first story in a five-part Reuters series on how weight-loss drugs are changing the way people shop and eat, and how companies are responding to the trend. Reuters spoke to eight fragrance manufacturers and top perfume brands. The conversations revealed how they are assessing GLP-1 users' responses to food-linked smells. Common negative side effects of GLP-1 weight-loss drugs ⁠like Novo Nordisk's Wegovy and Eli Lilly's Mounjaro include nausea and gastrointestinal issues. Researchers are also looking at other potential effects, some unexpected, including a reduction in alcohol cravings or urges to gamble and impulse-shop, and changes to smell and taste. Read the full article   Sponsors are not involved in the creation of newsletters or other Reuters news content. Advertise in this newsletter or on Reuters' website   Reuters One Essential Read is sent three days a week. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here. Want to stop receiving this email? Unsubscribe here. To manage which newsletters you're signed up for, click here. This email includes limited tracking for Reuters to understand whether you’ve engaged with its contents. For more information on how we process your personal information and your rights, please see our Privacy Statement. Terms & Conditions   © 2026 Thomson Reuters. All rights reserved. 3 Times Square, New York, NY 10036

S&P 500, Nasdaq futures rise as AI stocks rebound ahead of key earnings

S&P 500 and Nasdaq ​futures gained on Monday as AI-related shares rebounded from last week's sharp selloff, while ‌a decline in oil prices and Treasury yields provided additional support ahead of key earnings reports from major technology companies this week.

Reuters Business Reuters Business

S&P 500, Nasdaq futures rise as AI stocks rebound ahead of key earnings

Under Trump, deficits remain high while borrowing costs escalate

Fed sees AI boom adding to inflation headache, but others may pay for the medicine

SpaceX, Tesla earnings to test Musk's AI spending ambitions as merger talk grows

How one hacker used AI agents and a few thousand dollars to break into scores of sites

Netflix faces questions on user engagement ahead of third-quarter report

Tesla asks shareholders to re-elect Musk, Denholm and Straubel at December annual meeting

JPMorgan announces $5 billion in investments in companies critical to US national security

Albertsons begins its $8 billion trial against Kroger over failed merger

Cherry or tabasco? Perfumers test weight-loss drug users' appetite for food-inspired scents

Sponsors are not involved in the creation of newsletters or other Reuters news content. Advertise in this newsletter or on Reuters' website   Reuters Business is sent every weekday. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here. Want to stop receiving this email? Unsubscribe here. To manage which newsletters you're signed up for, click here. This email includes limited tracking for Reuters to understand whether you’ve engaged with its contents. For more information on how we process your personal information and your rights, please see our Privacy Statement. Terms & Conditions   © 2026 Thomson Reuters. All rights reserved. 3 Times Square, New York, NY 10036